Your browser doesn't support javascript.
loading
Stepwise pathogenic evolution of Mycobacterium abscessus.
Bryant, Josephine M; Brown, Karen P; Burbaud, Sophie; Everall, Isobel; Belardinelli, Juan M; Rodriguez-Rincon, Daniela; Grogono, Dorothy M; Peterson, Chelsea M; Verma, Deepshikha; Evans, Ieuan E; Ruis, Christopher; Weimann, Aaron; Arora, Divya; Malhotra, Sony; Bannerman, Bridget; Passemar, Charlotte; Templeton, Kerra; MacGregor, Gordon; Jiwa, Kasim; Fisher, Andrew J; Blundell, Tom L; Ordway, Diane J; Jackson, Mary; Parkhill, Julian; Floto, R Andres.
Afiliação
  • Bryant JM; Molecular Immunity Unit, University of Cambridge Department of Medicine, MRC Laboratory of Molecular Biology, Cambridge, UK.
  • Brown KP; University of Cambridge Centre for AI in Medicine, Cambridge, UK.
  • Burbaud S; Molecular Immunity Unit, University of Cambridge Department of Medicine, MRC Laboratory of Molecular Biology, Cambridge, UK.
  • Everall I; Cambridge Centre for Lung Infection, Royal Papworth Hospital, Cambridge, UK.
  • Belardinelli JM; Molecular Immunity Unit, University of Cambridge Department of Medicine, MRC Laboratory of Molecular Biology, Cambridge, UK.
  • Rodriguez-Rincon D; Molecular Immunity Unit, University of Cambridge Department of Medicine, MRC Laboratory of Molecular Biology, Cambridge, UK.
  • Grogono DM; Wellcome Sanger Institute, Hinxton, UK.
  • Peterson CM; Mycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins CO, USA.
  • Verma D; Molecular Immunity Unit, University of Cambridge Department of Medicine, MRC Laboratory of Molecular Biology, Cambridge, UK.
  • Evans IE; Molecular Immunity Unit, University of Cambridge Department of Medicine, MRC Laboratory of Molecular Biology, Cambridge, UK.
  • Ruis C; Cambridge Centre for Lung Infection, Royal Papworth Hospital, Cambridge, UK.
  • Weimann A; Mycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins CO, USA.
  • Arora D; Mycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins CO, USA.
  • Malhotra S; Molecular Immunity Unit, University of Cambridge Department of Medicine, MRC Laboratory of Molecular Biology, Cambridge, UK.
  • Bannerman B; Cambridge Centre for Lung Infection, Royal Papworth Hospital, Cambridge, UK.
  • Passemar C; Molecular Immunity Unit, University of Cambridge Department of Medicine, MRC Laboratory of Molecular Biology, Cambridge, UK.
  • Templeton K; University of Cambridge Centre for AI in Medicine, Cambridge, UK.
  • MacGregor G; Molecular Immunity Unit, University of Cambridge Department of Medicine, MRC Laboratory of Molecular Biology, Cambridge, UK.
  • Jiwa K; University of Cambridge Centre for AI in Medicine, Cambridge, UK.
  • Fisher AJ; Molecular Immunity Unit, University of Cambridge Department of Medicine, MRC Laboratory of Molecular Biology, Cambridge, UK.
  • Blundell TL; Department of Biochemistry, University of Cambridge, Cambridge CB2 1GA, UK.
  • Ordway DJ; Scientific Computing Department, Science and Technology Facilities Council, Harwell, UK.
  • Jackson M; Molecular Immunity Unit, University of Cambridge Department of Medicine, MRC Laboratory of Molecular Biology, Cambridge, UK.
  • Parkhill J; University of Cambridge Centre for AI in Medicine, Cambridge, UK.
  • Floto RA; Molecular Immunity Unit, University of Cambridge Department of Medicine, MRC Laboratory of Molecular Biology, Cambridge, UK.
Science ; 372(6541)2021 04 30.
Article em En | MEDLINE | ID: mdl-33926925
ABSTRACT
Although almost all mycobacterial species are saprophytic environmental organisms, a few, such as Mycobacterium tuberculosis, have evolved to cause transmissible human infection. By analyzing the recent emergence and spread of the environmental organism M. abscessus through the global cystic fibrosis population, we have defined key, generalizable steps involved in the pathogenic evolution of mycobacteria. We show that epigenetic modifiers, acquired through horizontal gene transfer, cause saltational increases in the pathogenic potential of specific environmental clones. Allopatric parallel evolution during chronic lung infection then promotes rapid increases in virulence through mutations in a discrete gene network; these mutations enhance growth within macrophages but impair fomite survival. As a consequence, we observe constrained pathogenic evolution while person-to-person transmission remains indirect, but postulate accelerated pathogenic adaptation once direct transmission is possible, as observed for M. tuberculosis Our findings indicate how key interventions, such as early treatment and cross-infection control, might restrict the spread of existing mycobacterial pathogens and prevent new, emergent ones.
Assuntos

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Pneumonia Bacteriana / Evolução Molecular / Doenças Transmissíveis Emergentes / Aptidão Genética / Mycobacterium abscessus / Pulmão / Infecções por Mycobacterium não Tuberculosas Limite: Humans Idioma: En Revista: Science Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Pneumonia Bacteriana / Evolução Molecular / Doenças Transmissíveis Emergentes / Aptidão Genética / Mycobacterium abscessus / Pulmão / Infecções por Mycobacterium não Tuberculosas Limite: Humans Idioma: En Revista: Science Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido